Post #1758

Tomorrow is the TGE date for LAB – a 30x oversubscribed round on Nozomi (Legion). Here's my classic investment memo that addresses the major strengths and weaknesses of the product. Major highlight: 80% of revenue used for buybacks; protocol already generates good revenue.